HLTH Forward Podcast

Smriti Kirubanandan

HLTH (Health) Forward is where we hold space for Healthcare leaders, physicians, and key health policymakers to discuss what takes us to move Healthcare Forward. We want to hear challenges, ideas, and out-of-the-box solutions for us to unite our ecosystems further and move the needle towards an innovative, affordable, and all-inclusive healthcare ecosystem. * Not affiliated with HLTH events

  1. Left Behind: The DNA We Don't Know We're Sharing, Heather Dewey-Hagborg, Information and Bio Artist

    1D AGO

    Left Behind: The DNA We Don't Know We're Sharing, Heather Dewey-Hagborg, Information and Bio Artist

    In this episode, I sit down with Heather, an artist who has spent over a decade at the intersection of biotechnology, surveillance, and identity. What began as a quiet moment in a therapy session — staring at a strand of hair caught in cracked glass — became a decade-long investigation into what our discarded DNA reveals about us. Heather collects cigarette butts, chewed gum, hair, and nail clippings from public spaces, extracts the DNA, and uses it to reconstruct 3D-printed portraits of complete strangers — people who never consented to being seen, never knew they left something behind, and never imagined they'd end up on a gallery wall. I found this conversation deeply philosophical, and it made me rethink something I'd never considered: that every step we take, every cup of coffee we leave behind, we are quietly shedding a biological story that anyone — artist, scientist, or law enforcement — could one day pick up and read. But for the HLTHForward audience, this goes far beyond art. The same DNA that can reconstruct a face holds a map to our health — our ancestry, our inherited risks, and the diseases that may one day find us before we ever see them coming. Heather also opened my eyes to something that I think we all take for granted: every consent form we sign at a doctor's visit, every biopsy, every blood draw — that data lives on, changes hands, and we rarely ask where it goes. This conversation with Heather is about art, yes, but it's really about identity, privacy, and what it means to truly know yourself — and others — at the most fundamental biological level. It's one of those episodes that will change how you move through the world. About Heather Dewey-Hagborg is an information artist and biohacker whose work lives at the uneasy edge of science, surveillance, and what it means to be seen. Born in Philadelphia in 1982 and based in Brooklyn, New York, she is best known for Stranger Visions — a series of hyper-realistic 3D-printed portraits constructed entirely from DNA recovered from discarded objects: a cigarette butt on a subway grate, a strand of hair on a park bench, a piece of chewing gum left on the sidewalk. From those fragments, she extracted genetic data, determined traits like gender, ethnicity, and facial structure, and used face-generating software and a 3D printer to bring a stranger's face to life — without ever meeting them. Her work is as provocative as it is precise. Equal parts artist and scientist, Dewey-Hagborg doesn't just make art — she asks questions the rest of us haven't thought to ask yet: Who owns the DNA you leave behind? What does your biology say about you without your permission? And what happens when the same technology that reconstructs a face can also predict a disease? With no clear legal precedent governing what she does, her practice sits in a space that is simultaneously legal, deeply intimate, and quietly radical — forcing us to reckon with how much of ourselves we unknowingly give away every single day. Support the show

    38 min
  2. The Wand Reimagining Cervical Cancer Screening: Kara Egan, CEO and Founder @Teal Health

    APR 20

    The Wand Reimagining Cervical Cancer Screening: Kara Egan, CEO and Founder @Teal Health

    Every time a friend mentions her annual checkup, the conversation sounds less like healthcare and more like a horror story. Stirrups. A speculum. A procedure that hasn't meaningfully changed in 150 years — a tool designed before women could vote, still showing up in exam rooms like it owns the place. So when I sat down with Kara Egan, CEO and co-founder of Teal Health, I came in with real questions. Here's the number that stopped me cold: 4,200 women die from cervical cancer every year in the United States. Not because we lack the science. We have the vaccine. We have decades of research. And yet 1 in 3 women are behind on their screenings — and it's getting worse. The barriers aren't medical. They're logistical. Kara didn't set out to build a medical device company. She came up through health tech investing, had a baby, and realized it was genuinely easier to order a coffee than schedule a doctor's appointment. She met her co-founder, who had built the first prototype of the Teal Wand at Stanford Biodesign. Covid hit. Telehealth exploded. She saw the opening. What Teal built is an at-home HPV self-collection kit — a small wand, used privately, on your own schedule. Mail the sample. Get your results. No stirrups. No six-month wait. FDA authorized in May 2025. Nationwide by January 2026. Nearly half of Teal's customers were behind on screenings. Almost 20% had never been screened at all — not because they didn't care, but because the system was never designed for them. And starting January 1st, 2027, federal guidelines require it to be covered with zero cost-sharing for anyone with insurance. No copay. No deductible. Effectively free. Mark it. About Kara Egan is the CEO and co-founder of Teal Health, the company behind the first FDA-authorized at-home cervical cancer screening kit in the United States. Named to TIME's Best Inventions of 2025, she has spent her career at the intersection of healthcare and technology — as a health tech investor, software investor, and operator at companies like Zendesk. A Stanford and Wharton alumna, Kara co-founded Teal in 2020 after recognizing that women's healthcare was long overdue for a redesign. In May 2025, the FDA authorized the Teal Wand, and by January 2026, it was available in all 50 states. She is on a mission to eliminate cervical cancer — a disease that is almost entirely preventable — by making screening accessible to every woman, everywhere. Support the show

    28 min
  3. Beyond the Incision: Oliver Keown, CEO & Founder , Oath Surgical

    MAR 23

    Beyond the Incision: Oliver Keown, CEO & Founder , Oath Surgical

    Sitting down with Oliver, the CEO of Oath Surgical, felt less like conducting a typical healthcare interview and more like getting a front-row seat to how the future of surgery might be built. As someone whose career spans clinical surgery, medical technology, venture investing, and surgical innovation, Oliver brings a rare perspective to the conversation. Early in his career he trained as a physician in the UK, with surgical rotations in orthopedics, ENT, and colorectal surgery. However, he soon realized that his real calling was not just practicing surgery but shaping how surgical care evolves. His time working with companies like Intuitive Surgical and investing in early-stage healthcare technologies exposed him to the broader structural challenges of surgical care and convinced him that incremental improvements to the existing system would never be enough. One of the most striking insights Oliver shared during our conversation was the scale of the problem in the current healthcare system. Surgery is one of the largest cost drivers in healthcare, representing more than $1 trillion in annual spending in the United States alone. Yet a significant portion of surgical procedures that are performed in hospitals today could safely be done in outpatient surgical centers. According to Oliver, moving appropriate surgeries into outpatient environments can reduce costs by 50% to 80% while maintaining or even improving patient outcomes. This realization became the foundation of what Oath Surgical is building: a next-generation model for delivering complex surgical care in a more efficient, technology-enabled environment. At its core, Oath Surgical is creating a national network of premium outpatient surgical centers that are co-owned and operated with high-performing surgeons. The philosophy behind the model is straightforward but powerful—surgeons should lead the system, technology should support it, and the entire structure should be aligned around delivering measurable value. Instead of simply operating facilities, the company is building a digitally integrated surgical platform that connects surgeons, facilities, and patients through a unified operating system. This allows Oath Surgical to focus on three critical dimensions simultaneously: better outcomes for patients, improved experiences for surgeons, and lower overall costs for the healthcare system. A particularly fascinating aspect of our conversation centered on how Oath Surgical approaches data and artificial intelligence. Rather than layering software tools on top of existing hospital infrastructure, Oliver explained that the company is rebuilding the entire system from the ground up. Their platform integrates data from multiple sources across the entire surgical journey, including clinical records, operational workflows, patient-reported outcomes, inventory and financial systems, and even ambient data from surgical videos and sensors. By structuring this data across the full care episode, the platform creates a longitudinal view of surgical performance and patient recovery that traditional hospital systems rarely achieve. This integrated data architecture enables a wide range of AI-driven capabilities designed to reduce administrative burden and improve efficiency. Tasks that often consume hours of clinician time—such as documentation, scheduling, referrals, and coding—can increasingly be automated. Oliver described this vision as moving toward “zero documentation workflows,” where surgeons and clinical teams spend less time interacting with computers and more time focusing on patient care. In this model, artificial intelligence operates quietly in the background, handling operational complexity while leaving clinical decision-making firmly in the hands of medical professionals. Despite the growing role of AI in healthcare, Oliver was very clear th Support the show

    22 min
  4. Strengthening The Frontlines : Stephen Beard, Chairman and CEO, Covista

    MAR 12

    Strengthening The Frontlines : Stephen Beard, Chairman and CEO, Covista

    In this episode of HLTH Forward, I sit down with Steve Beard for a candid conversation about one of the most urgent issues in healthcare today—the people who deliver care, and the system that is pushing many of them to the brink. Across the United States, the numbers tell a powerful story: about 43% of physicians report experiencing symptoms of burnout, and nearly two-thirds of nurses—around 65%—say they are experiencing high levels of burnout. The pressure is enormous, and the cost is not only personal—it’s systemic, with burnout estimated to cost the U.S. healthcare system about $4.6 billion each year due to turnover and reduced clinical hours.   76% of clinicians say staffing shortages are preventing them from delivering high-quality care Stress reduction ranks as clinicians' second-highest workplace priority — just behind adequate staffing itselfDespite relatively high job satisfaction, 15% of physicians and 13% of nurses say they're likely to leave the profession within the next yearAs I talk with Steve, we explore what these numbers really mean for the future of healthcare. Behind every statistic is a physician working late to finish electronic records, a nurse covering extra shifts because a unit is short-staffed, or a clinician questioning how long they can keep up the pace. Research shows physicians are over 80% more likely to experience burnout than workers in other professions, and many say the growing administrative burden and regulatory complexity are major contributors.  These realities are exactly why conversations about workforce sustainability, training, and support systems are no longer optional—they are essential. In my conversation with Steve, we talked about how leadership, communication, and collaboration across healthcare ecosystems can help address these pressures and ultimately build a more resilient workforce. Because if healthcare is at a turning point, the real question isn’t just how we got here—it’s how leaders, organizations, and communities come together to shape what comes next. About Covista (formerly Adtalem Global Education) is a major U.S. healthcare educator, serving over 97,000 students through five accredited institutions—including Chamberlain University and Walden University—focused on closing workforce gaps. The company emphasizes tech-enabled education, AI-driven innovation, and directly connecting graduates to healthcare systems Support the show

    19 min
  5. Rewriting Menopause Care, Joanna Strober, CEO and Founder @Midi Health

    JAN 21

    Rewriting Menopause Care, Joanna Strober, CEO and Founder @Midi Health

    In my conversation with Joanna Strober, CEO of Midi Health, a recentl Times 100 Health awardee, we explored the current landscape of menopause care — a space where millions of women experience significant symptoms yet remain underserved by traditional healthcare systems.  Despite hormone therapy being one of the most effective treatments for menopause symptoms such as hot flashes, mood swings, sleep disturbances, and fatigue, usage rates remain strikingly low; recent research shows that fewer than 4% of women aged 45–59 use hormone therapy, even though up to 80% of women are affected by symptoms at some point in midlife. Compounding this care gap is a broader systemic challenge: only about one in five obstetricians/gynecologists and even fewer primary care physicians receive formal training in menopause management, leaving many women without knowledgeable clinicians to guide them through this critical life stage.  Meanwhile, perimenopause — when hormone levels surge and crash unpredictably — can begin years before the final period and trigger mood fluctuations, physical changes, brain fog, and anxiety, underscoring the emotional and physiological complexity of this transition. Against this backdrop, Midi Health has emerged as a provider platform designed specifically to support women’s menopause journeys with personalized, evidence-based care that meets patients where they are.  Launched to close the care gap that traditional healthcare has long ignored, Midi leverages a nationwide telehealth model with clinicians trained in midlife women’s health protocols, offering both hormonal and non-hormonal treatment plans that are often covered by insurance.  With tens of thousands of patients served and ambitious plans to scale to care for more than a million women per year, the company is striving to transform how women experience midlife health — from dismissive, fragmented care to proactive, supportive treatment that acknowledges both the physical and emotional effects of menopause at scale Support the show

    24 min
  6. Unbroken: The Noma Survivor Changing Global Health, Fidel Strub

    JAN 3

    Unbroken: The Noma Survivor Changing Global Health, Fidel Strub

    In this HLTH Forward episode, I spoke with Fidel Strub, and I felt the kind of strength and hope that transforms pain into power. He isn’t just a survivor — he is living proof that with knowledge, compassion, and action, tragedy can become a force for change. According to the World Health Organization, Noma — the devastating, gangrenous disease that ravages the mouths and faces of malnourished children — once afflicted an estimated 140,000 individuals per year globally, with a case-fatality rate as high as 90%.  Survivors often endure severe disfigurement, lifelong difficulties eating, speaking, or breathing, and face social isolation — yet many never receive timely treatment, because far too many healthcare workers don’t recognize Noma early enough.  Fidel shared that surviving Noma gave him a “second chance at life.” But survival alone wasn’t enough — dignity, acceptance, and opportunity were what truly mattered. As a co-founder of the survivor-led advocacy group Elysium, he and his fellow survivors turned personal trauma into a public mission. Their campaign helped ensure that in 2023, Noma was finally added to the WHO’s official list of neglected tropical diseases. This milestone opens the door to funding, research, education, and treatment. Now he champions early detection, basic antibiotic treatment, and reconstructive surgery — but most of all, he fights for the right of survivors to be seen as people deserving of dignity, not pity. And Noma is far from an isolated tragedy. Across the globe, millions suffer from rare diseases — deeply misunderstood, under diagnosed, and grossly under-resourced. Experts estimate there are more than 7,000 rare diseases worldwide, affecting up to 3.5–5.9% of the global population — that’s hundreds of millions of people.   Many begin in childhood: around 70 % of rare diseases are genetic, and a significant proportion manifest before adulthood. Yet over 95% of these conditions lack an approved treatment, reflecting a shocking disparity between need and support.  At its core, Fidel’s story — and the broader rare-disease crisis — challenges us to expand our vision of healthcare and humanity. It’s not just about surviving illnesses; it’s about ensuring dignity, inclusion, and opportunity for every human being, regardless of where they were born or how rare their condition.  Support the show

    31 min
  7. Molecules of the Mind: Dr. Eric Nestler on the Biology of Addiction and Depression, Mt.Sinai Health System

    10/06/2025

    Molecules of the Mind: Dr. Eric Nestler on the Biology of Addiction and Depression, Mt.Sinai Health System

    In this episode, featuring Dr. Eric Nestler, offers a fascinating glimpse into the intersection of neuroscience, addiction, and depression. Dr. Nestler explains that both conditions share similar brain mechanisms, particularly within the limbic system, which regulates emotion and motivation. His laboratory’s research delves into how chronic stress or drug exposure alters molecular pathways in these emotional brain regions, leading to maladaptive behaviors. Through advanced techniques like transcriptomics, his team analyzes thousands of brain molecules simultaneously, helping to uncover key differences between healthy and diseased brains. This cutting-edge work not only enhances our understanding of mental health disorders but also opens new possibilities for targeted treatments and resilience-building therapies. Beyond the science, Dr. Nestler highlights broader social and ethical dimensions. He emphasizes that the global rise in addiction and depression reflects modern societal stressors—social isolation, technological pressures, and post-pandemic effects.  While innovative approaches like AI-driven analysis and brain–computer interfaces show promise, he cautions that such technologies must be pursued with great ethical care. Ultimately, his message centers on balance: advancing research while nurturing everyday resilience through healthy living, social connection, and emotional awareness. His closing insight—that true health comes from integrating science, empathy, and humanity—resonates as both hopeful and urgent for the future of healthcare. About Dr. Eric J. Nestler, MD, PhD, is a leading neuroscientist and physician renowned for his groundbreaking research on the molecular and epigenetic mechanisms underlying depression and drug addiction. Currently serving as the Interim Dean of the Icahn School of Medicine at Mount Sinai and Chief Scientific Officer of the Mount Sinai Health System, Dr. Nestler has played a transformative role in advancing brain science through his leadership of the Friedman Brain Institute and his own laboratory’s work. His research has shed light on how chronic stress and repeated drug exposure alter gene expression and neural circuits, particularly through discoveries such as the transcription factor ΔFosB, a key regulator of long-term changes in the brain’s reward pathways. Dr. Nestler earned his BA, MD, and PhD from Yale University and has held prominent academic positions at Yale, UT Southwestern Medical Center, and Mount Sinai. He is an elected member of the National Academy of Sciences, the National Academy of Medicine, and the American Academy of Arts and Sciences, and has published hundreds of influential scientific papers. Deeply committed to diversity in science, Dr. Nestler is also known for promoting inclusive leadership and mentorship throughout his career. Support the show

    46 min

Ratings & Reviews

4.3
out of 5
6 Ratings

About

HLTH (Health) Forward is where we hold space for Healthcare leaders, physicians, and key health policymakers to discuss what takes us to move Healthcare Forward. We want to hear challenges, ideas, and out-of-the-box solutions for us to unite our ecosystems further and move the needle towards an innovative, affordable, and all-inclusive healthcare ecosystem. * Not affiliated with HLTH events